Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-12 08:27 am Purchase |
2024-07-15 | 13D | CASI Pharmaceuticals, Inc. CASI |
He Wei-Wu | 3,257,891 20.940% |
420,000 (+14.80%) |
Filing History |
| 2023-04-18 4:00 pm Purchase |
2023-04-14 | 13D | CASI Pharmaceuticals, Inc. CASI |
He Wei-Wu | 2,837,891 19.750% |
2,837,891 (New Position) |
Filing History |
| 2022-06-21 4:26 pm Purchase |
2022-06-13 | 13D | CASI Pharmaceuticals, Inc. CASI |
He Wei-Wu | 2,761,349 18.950% |
2,761,349 (New Position) |
Filing History |
| 2021-11-23 5:15 pm Purchase |
2021-11-18 | 13D | CASI Pharmaceuticals, Inc. CASI |
He Wei-Wu | 2,598,199 17.470% |
438,000 (+20.28%) |
Filing History |
| 2021-02-03 4:01 pm Purchase |
2021-02-01 | 13D | CASI Pharmaceuticals, Inc. CASI |
He Wei-Wu | 2,160,199 16.260% |
384,747 (+21.67%) |
Filing History |
| 2020-07-29 5:16 pm Purchase |
2020-07-24 | 13D | CASI Pharmaceuticals, Inc. CASI |
He Wei-Wu | 1,775,452 13.780% |
520,900 (+41.52%) |
Filing History |